Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Cancer Genetics, Inc. (CGI) is transforming the diagnosis and clinical management of the most complex and difficult to treat cancers with a focus in hematologic, urogenital and gynecological malignancies. Founded in 1999, CGI is committed to offering high quality products and services that assist clinicians, oncologists and pathologists in devising treatment plans for their patients that will increase efficacy and reduce healthcare costs.
Together we have been able to add and improve the processes to meet our customer needs, allowing us to offer high quality results and in a very short time to our patients.
Alvaro Soto, General Manager, Roche Central America and the Caribbean
Recent Milestones
CLL
CLL/SLL
DLBCL
MCL
2010
Summation Report is developed. MatBA-CLL CLIA approved.
2011
Launch of CLL CompleteSM. MatBA-CLL New York State licensed. CGI establishes Select One Clinical Trials Services. Expansion of Dx lab services: JAK2 & MPL mutation analysis, EGFR mutation analysis.
2012
MatBA-SLL CLIA & New York State approved. Expansion of Dx Lab services: Solid tumor, ALK Break Apart FISH, BRAF & KRAS mutation. Expansion of CLL CompleteSM testing; NOTCH1, TP53 mutation added.
2013
MatBA-DLBCL CLIA & New York State approved. UroGenRATM-Kidney CLIA and New York State approved. Launch of DLBCL CompleteSM. Expansion of CLL CompleteSM testing; SF3B1 mutation added. MatBA-MCL CLIA approved.
Clinical management team with an average of 15 years diagnostic experience in oncology Expertise in next generation molecular diagnostics Cutting-edge proprietary testing Center of Excellence for CLL and DLBCL Unique oncology focused R&D program Clinical expertise with access to key opinion leaders Research collaborations with major cancer centers (Memorial Sloan-Kettering Cancer Center, Cleveland Clinic) 99% of testing done under one roof allowing for superior turnaround time (TAT) Collaborations with pharmaceutical companies focused in clinical trials Easy access to test reports (HIPAA compliant): fax, email, web-based portal (cgireports.com) with EMR integration capacity
Main Phone: Lab Phone: Toll Free: Fax Line: +1.201.528.9200 +1.201.528.9187 888.334.4988 +1.201.528.9201
World-Class Oncology-Focused Diagnostics Laboratory CAP Certification 7191582 CLIA Accreditation 31D1038733 Florida License 800018142 Maryland License 1315 New Jersey License 0002299 New York License PFI 8192 Pennsylvania License 031978
Cancer Genetics, Inc. | 201 Route 17 North, 2nd Floor, Rutherford, NJ 07070 | 1.201.528.9200 | www.cancergenetics.com
2013 Cancer Genetics, Inc. All rights reserved. 032913